Nectar

What Nectar does

Nectar (legal entity Nectar Life Sciences, Inc., DBA Nectar Allergy & Asthma) is a vertically integrated allergy healthcare platform that combines an in-person clinical practice, a direct-to-consumer at-home testing and treatment subscription business, and a telehealth/virtual care delivery model. The company's core offering is custom-compounded sublingual immunotherapy (SLIT) drops and nasal sprays, manufactured in its own 503A compounding pharmacy (licensed across all 50 states) based on individual patient allergy test results. Supporting services include skin prick testing, blood allergy testing (via Quest Diagnostics and Labcorp), patch testing, oral food challenges, spirometry, nasal endoscopy, biologics (e.g., Xolair, Dupixent), rescue inhalers, and topical treatments. A single physical clinic operates at 176 3rd Avenue near Union Square in New York City, while at-home testing and SLIT subscriptions are delivered to consumers in 49 U.S. states (excluding New York).

The underlying technology stack includes a proprietary in-house patient portal (dashboard.mynectar.com) for booking, intake, prescription management, and follow-ups, integrated with the compounding pharmacy and EHR systems. Nectar reports using AI tools for clinical and administrative workflow efficiency, and has partnerships with Stripe (payments), Google (OAuth), and Amazon Cognito (identity management) on the platform side. Revenue is generated through three streams: recurring SLIT subscription revenue ($79-99/month or $900-$2,400 multi-year prepay), in-network insurance billing for in-person clinical services (Aetna, BCBS, Cigna, Emblem, Medicare, United Healthcare), and one-time at-home test kit sales (FSA/HSA eligible). Customer acquisition is predominantly DTC via social media (Facebook, Instagram, TikTok), SEO, and educational content marketing.

Nectar targets adults and children with environmental allergies, food allergies, asthma, and eczema — a population of more than 120 million Americans with allergies, described as the #1 U.S. chronic condition. The company reports 90% of patients experienced symptom improvement after three months on its protocol. Founded in 2021/2022, Nectar has raised approximately $24 million in total venture funding across an $8M seed round (Juxtapose, Obvious Ventures, March 2022) and a $16.5M Series A (Harmony Partners lead, December 2022), and operates with 11-50 employees from a remote-first model with a New York City headquarters.

Name

Nectar

Legal name

Nectar Life Sciences, Inc.

Website

https://mynectar.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

Nectar (Nectar Allergy & Asthma) is a vertically integrated allergy care platform operating a hybrid in-person NYC clinic, at-home testing nationwide, and DTC subscription for custom-compounded sublingual immunotherapy drops and nasal sprays, serving adults and children with environmental allergies, asthma, food allergies, and eczema.

Ownership category

akta.pro rank

Product category

Allergy & Immunology Healthcare Services

NAICS

Offices of Dentists (62121)

SIC

Services-Health Services (8000)

akta.pro primary industry

Allergen Immunotherapy (SCIT/SLIT) Services (HLAKAAAF)

akta.pro secondary industry

Allergy & Immunology Clinics (HLAKAAAA)

Keywords

• Allergy care services
• Sublingual immunotherapy
• Allergy testing
• Compounding pharmacy
• Telehealth allergy treatment

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Allergy Drop Subscriptions: Recurring subscription revenue from personalized sublingual immunotherapy (SLIT) allergy drops, available on monthly ($79-99/month) or annual prepay plans ($900-$2,400 upfront for 1-3 years). Drops are delivered quarterly to patients' homes. Subscription can be cancelled anytime.
2. In-Person Clinical Services: Fee-for-service revenue from in-person clinic visits at the NYC allergy clinic, including allergy testing (skin prick, blood, patch), oral food challenges, spirometry, nasal endoscopy, and other diagnostic and treatment services. Covered by multiple insurance plans including Aetna, BCBS, Cigna, Empire, Medicare, and others.
3. At-Home Testing Kits: Revenue from at-home environmental allergy test kits (blood spot finger-prick test measuring IgE antibodies for 40 common allergens). Currently not available in New York state. FSA/HSA eligible.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Nectar Allergy & Asthma is a vertically integrated allergy healthcare platform that diagnoses and treats environmental, food, and pediatric allergies, asthma, and eczema. Its core offering is custom-compounded sublingual immunotherapy (SLIT) allergy drops and nasal sprays produced at an in-house 503A compounding pharmacy, supported by in-clinic diagnostic services (skin prick, blood, patch testing, oral food challenges, spirometry, nasal endoscopy) and a direct-to-consumer online platform for at-home testing and recurring drop subscriptions. Care is delivered through a hybrid model combining the NYC Union Square clinic, telehealth, and mail-order subscription delivery.

Product overview

Nectar Allergy & Asthma is a comprehensive allergy care platform operating a hybrid care model that combines virtual telehealth services, at-home testing and treatment delivery, and in-person care at their NYC clinic. The platform centers on Allergy Drops (sublingual immunotherapy), which are custom-compounded and delivered to patients, supported by diagnostic services including Blood Allergy Testing, Skin Prick Testing, Patch Testing, and Oral Food Challenges. The company operates a 503A compounding pharmacy licensed in all 50 states for personalized medication formulation. Additional offerings include Respiratory treatments (Rescue Inhaler, Spirometry, Nasal Endoscopy), Skin treatments (Biologics, Topical Ointments, Skin Evaluations), and an At-Home Allergy Test kit. All services are managed through an in-house developed Patient Portal platform for appointment booking, prescription management, and care coordination.

Differentiator

Problem solved

Functional benefit

Products and services

• Allergy Drops (Sublingual Immunotherapy) Custom-formulated sublingual immunotherapy (SLIT) drops that treat environmental and food allergies by building long-term immunity. Drops are taken daily under the tongue, customized based on individual allergy test results, and delivered quarterly to patients' homes via subscription.
• Blood Allergy Testing Laboratory test measuring allergen-specific IgE antibodies in the blood to identify allergy triggers for foods, pollen, dust mites, pet dander, and mold. Blood draws performed at Quest Diagnostics or Labcorp specimen centers.
• Skin Prick Testing In-person allergy testing method where small amounts of allergens are applied to the skin to observe reactions. Results available same-day at the NYC clinic.
• Patch Testing Testing method for contact allergies to metals, fragrances, and preservatives by observing skin reactions from allergen contact.
• Oral Food Challenges Diagnostic test performed in-clinic under medical supervision to confirm food allergies by having patients consume increasing amounts of a suspected allergen to check for reactions.
• Rescue Inhaler Bronchodilator medication prescribed by Nectar providers for rapid relief from acute respiratory symptoms associated with asthma, including wheezing, chest tightness, shortness of breath, and coughing.
• Spirometry Breathing test measuring lung function by assessing how much air can be inhaled and exhaled and how quickly. Helps diagnose asthma and allergic bronchitis.
• Nasal Endoscopy In-office procedure examining nasal passages and sinuses to identify chronic inflammation, polyps, or anatomical issues contributing to allergies.
• Nasal Spray Rx Compounded nasal spray treatments prescribed by Nectar's licensed providers, personalized to each patient's allergen profile.
• Biologics Injectable treatments to reduce allergic reactions for conditions like asthma and eczema, including medications such as omalizumab (Xolair) and dupilumab (Dupixent).
• Topical Ointments Prescription topical treatments for managing allergic itching and inflammation associated with eczema and skin allergies.
• Skin Evaluations Clinical assessments for skin conditions including eczema and hives, performed by allergists to identify and diagnose allergic skin conditions.
• At-Home Allergy Test At-home blood IgE test measuring the body's response to 40 common indoor and outdoor allergens including pets, trees, weeds, grasses, molds, and dust mites. Available in all U.S. states except New York. FSA/HSA eligible.
• NYC Allergy Clinic Physical allergy clinic at 176 3rd Avenue, New York, NY 10003, offering in-person testing, treatment, and consultations for environmental allergies, asthma, food allergies, eczema, and pediatric allergies. Accepts in-network and out-of-network insurance, Medicare, and Medicaid.
• 503A Compounding Pharmacy In-house 503A compounding pharmacy licensed in all 50 states, offering customized sublingual immunotherapy (SLIT), nasal sprays, and other personalized therapies.

Quantifiable outcome

• 90% of patients experienced improvement in their allergy symptoms after three months with Nectar
• +1 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature4 records

Partnerships

Two partnerships are on record, tiered minor.

• NYU Langone HealthminorStrategic or Co-development PartnerDisplayed as a credentialing association on the Nectar website, suggesting clinical affiliations or shared professional networks with NYU Langone Health allergy specialists.
• Stanford UniversityminorStrategic or Co-development PartnerDisplayed as a credentialing association on the Nectar website, suggesting clinical affiliations or professional networks with Stanford University-trained allergy specialists.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Wyndly: Telehealth allergy clinic providing at-home testing and personalized sublingual immunotherapy drops on a subscription basis, directly overlapping Nectar's core DTC offering.
• Curex: Direct-to-consumer telehealth allergy platform offering at-home allergy testing and sublingual immunotherapy subscriptions - the closest direct competitor to Nectar's at-home SLIT business model.
• Allermi: Custom-formulated multi-ingredient nasal spray and allergy care platform serving allergy sufferers via telehealth - directly comparable to Nectar's compounded nasal sprays and personalized allergy approach.
• Sesame: DTC telehealth marketplace offering direct-pay visits with specialists including allergists, with a self-serve online booking flow that mirrors Nectar's patient portal experience.

Broad incumbents

• Hims & Hers Health: Large-scale DTC subscription telehealth platform with an expanding allergy and immunology offering; serves as a broad incumbent demonstrating the consumer demand and unit economics for subscription-based virtual care models that Nectar operates within.
• Ro: Multi-specialty DTC telehealth and pharmacy platform with vertically integrated compounding; comparable business model architecture (telehealth + in-house pharmacy + subscription) even though allergy is not its core vertical.
• ALK-Abelló: Global pharmaceutical company and leading manufacturer of FDA-approved allergy immunotherapy products (including sublingual tablets); a broad incumbent whose approved SLIT products compete with Nectar's compounded SLIT for prescriber attention and patient dollars.
• Stallergenes Greer: Established specialty pharmaceutical company focused on allergen immunotherapy (sublingual and subcutaneous), positioning it as a broader incumbent competing for the same immunotherapy demand that Nectar addresses.

Emerging players

• Antidote Health: Telehealth platform with allergy and immunology services delivered virtually; an emerging player with partial overlap to Nectar's online allergy consultation offering.

Others

• NYU Langone Allergy & Immunology: Academic medical center allergy clinic cited as a credentialing association on Nectar's website; representative of traditional in-person allergy specialty care that Nectar's hybrid model competes against for insured patients.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/getmynectar
• Instagraminstagram.com/getmynectar
• TikToktiktok.com/@getmynectar
• LinkedInlinkedin.com/company/getmynectar

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nectar